Community Oncology Alliance
Advocating for community oncology practices
Based in VA
🤖
AI Overview
With $3.2M in lobbying spend across 40 quarterly filings, Community Oncology Alliance is a significant lobbying presence. They deploy 12 individual lobbyists Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$3.2M
Total Spend
8
Years Active
1
Firms Hired
12
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $320K |
| 2019 | $800K |
| 2020 | $400K |
| 2021 | $400K |
| 2022 | $320K |
| 2023 | $320K |
| 2024 | $320K |
| 2025 | $320K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Veterans, Health Issues, Medicare/Medicaid
- •Issues related to pharmacy benefit managers.
- •Issues relating to VA claw back on reimbursements for community providers
- •Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; H.R. 1
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Healthcare Distribution Alliance (Formerly - Hdma)
$13.2M total spend
National Hospice and Palliative Care Organization
$5.0M total spend
Healthcare Distribution Alliance (Healthcare Distribution Managment Assn.)
$2.9M total spend
Healthcare Distribution Alliance
$1.7M total spend
Zero - the End of Prostate Cancer
$1.6M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.